PD-L1 Expression As Biomarker of Efficacy of PD-1/PD-L1 Checkpoint Inhibitors in Metastatic Triple Negative Breast Cancer: A Systematic Review and Meta-Analysis
FRONTIERS IN IMMUNOLOGY（2023）
关键词
breast cancer,immunotherapy,immune checkpoint inhibitors (ICI),pembrolizumab,atezolizumab,survival,immune-related toxicity
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要